TSLP and acute lymphoblastic leukemia: We detected that high doses of TSLP significantly decreased (p < 0.001, Figure 4B,D; p = 0.02, Figure 4F) the engraftment of CRLF2 B-ALL cells in the bone marrow of PDX-1 and PDX-2 (Figure 4B,D,F).